Here you can browse the complete list of projects on CDAS whose requests for data/biospecimens were approved.
Filter results of approved projects table below
| Name | Principal Investigator | Institution | Study | Date Approved | Project ID |
|---|---|---|---|---|---|
| ovarian cancer screening in a high risk population | Keith Terada | University of Hawaii | PLCO | May 21, 2014 | PLCO-89 |
| Ovarian Volume and Hormone Levels | Amanda Black | NCI, DCEG, EBP | PLCO | Apr 29, 2014 | PLCO-71 |
| Ovarian Volume: Determinants And Associations with Cancer Among Postmenopausal Women | Mark Sherman | NCI, DCEG, HREB | PLCO | Jul 1, 2006 | 2006-0233 |
| Overdiagnosis and alternative endpoints in cancer screening trials (OVERCAST) | Hilary Robbins | International Agency for Research on Cancer (IARC) | NLST | Jan 27, 2025 | NLST-1383 |
| Overdiagnosis and alternative endpoints in cancer screening trials (OVERCAST) | Hilary Robbins | International Agency for Research on Cancer (IARC) | PLCO | Jan 27, 2025 | PLCO-1800 |
| Overdiagnosis and alternative endpoints in cancer screening trials (OVERCAST) | Hilary Robbins | International Agency for Research on Cancer (IARC) | HIPB | Jan 24, 2025 | HIPB-16 |
| Overdiagnosis and alternative endpoints in cancer screening trials (OVERCAST) | Hilary Robbins | International Agency for Research on Cancer (IARC) | MINN | Feb 14, 2025 | MINN-7 |
| Overview of Trends from Repeated PSA Screening for Prostate Cancer: Report from the PLCO Cancer Screening Trial (The next results of screening Post T0 Paper using T0-T3 data) | Gerald Andriole | Washington University in St. Louis | PLCO | Jul 1, 2006 | 2006-0031 |
| Oxford Pooling Project: Prostate (endogenous hormones and nutritional biomarkers) | Amanda Black | NCI, DCEG, EBP | PLCO | Jan 31, 2011 | 2010-0320 |
| Oxford Pooling Project: Prostate (endogenous hormones and nutritional biomarkers):Updated | Amanda Black | NCI | PLCO | Mar 2, 2018 | PLCO-350 |
| Pan-cancer analyses of imaging-clinical phenotype associations | Kun-Hsing Yu | Harvard Medical School | PLCO | Sep 20, 2019 | PLCOI-523 |
| Pan-cancer analyses of imaging-clinical phenotype associations using updated PLCO cohorts | Kun-Hsing Yu | President and Fellows of Harvard College | PLCO | Mar 25, 2024 | PLCOI-1509 |
| Pan cancer deep learning model for predicting outcome of cancer | Andreas Kleppe | Institute for Cancer Genetics and Infomatics, Oslo University Hospital | PLCO | Aug 15, 2024 | PLCOI-1639 |
| Pan-cancer digital pathology AI foundation model and its application in cancer prognostication | Jan Witowski | Ataraxis AI, Inc. | PLCO | Jan 9, 2024 | PLCOI-1433 |
| Pan-cancer genome-wide association study of tissue disruption phenotypes on standard histologic images from PLCO | Mustapha Abubakar | Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, USA | PLCO | Mar 8, 2023 | PLCOI-1172 |
| Pan-Cancer Risks and Mortality: Multidimensional Associations with Lifestyle, Sociodemographics, and Diet/Nutrition Using the PLCO Database | Yuxiang Luo | Erasmus University Medical Center | PLCO | Apr 21, 2025 | PLCO-1886 |
| Pancreas Cancer Early Detection | Paul Lampe | Fred Hutchinson Cancer Research Center | PLCO | Oct 22, 2012 | 2012-0229 |
| Pancreas cancer incidence and mortality by NLST trial arm | Pamela Marcus | NCI | NLST | Apr 8, 2016 | NLST-206 |
| Pancreatic Cancer Genome Wide Association Study - PanScan | Laufey Amundadottir | National Cancer Institution | PLCO | Sep 27, 2021 | PLCO-548 |
| Pancreatic Cancer Prediction using Machine Learning | Akshay Bodkhe | San Jose State University | PLCO | Mar 2, 2017 | PLCO-259 |